XML 40 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2024
Stockholders’ Equity [Abstract]  
Schedule of Restricted Stock Awards

Based on the closing market price of our common stock on September 30, 2024 of $15.51 and December 31, 2023 of $16.18, the aggregate intrinsic value of our restricted stock awards was as follows:

 

 

As of September 30, 2024

 

 

As of December 31, 2023

 

 

Outstanding

 

 

Vested

 

 

Outstanding

 

 

Vested

 

Aggregate intrinsic value

 

$

6,611,324

 

 

$

2,935,112

 

 

$

5,525,370

 

 

$

937,068

 

Schedule of Restricted Stock Activity

The following table summarizes the restricted stock activity for the Company’s directors and officers and employees of the Manager during the nine months ended September 30, 2024 and 2023.

 

 

Nine months ended
September 30,
2024

 

 

Weighted Average Grant Date
Fair Value
per Share

 

Balance at December 31, 2023

 

 

366,647

 

 

$

14.86

 

Granted

 

 

187,335

 

 

$

15.59

 

Vested

 

 

(127,720

)

 

$

14.89

 

Unvested Balance at September 30, 2024

 

 

426,262

 

 

$

15.17

 

 

 

Nine months ended
September 30,
2023

 

 

Weighted Average Grant Date
Fair Value
per Share

 

Balance at December 31, 2022

 

 

80,984

 

 

$

15.71

 

Granted

 

 

323,452

 

 

$

14.75

 

Vested

 

 

(20,648

)

 

$

16.00

 

Forfeited

 

 

(1,147

)

 

$

16.00

 

Unvested Balance at September 30, 2023

 

 

382,641

 

 

$

14.88